Embree Financial Group Sells 2,350 Shares of CME Group Inc. (NASDAQ:CME)

Embree Financial Group decreased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 4.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 50,929 shares of the financial services provider's stock after selling 2,350 shares during the period. CME Group makes up 2.0% of Embree Financial Group's holdings, making the stock its 9th largest position. Embree Financial Group's holdings in CME Group were worth $11,237,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Capital International Investors grew its holdings in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider's stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. Ameriprise Financial Inc. increased its position in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock valued at $1,038,676,000 after buying an additional 537,758 shares in the last quarter. GUARDCAP ASSET MANAGEMENT Ltd raised its stake in CME Group by 1.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider's stock worth $863,112,000 after buying an additional 43,293 shares during the period. Raymond James & Associates grew its stake in CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider's stock valued at $595,530,000 after acquiring an additional 94,302 shares during the period. Finally, Legal & General Group Plc increased its holdings in shares of CME Group by 6.6% in the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider's stock worth $557,371,000 after acquiring an additional 176,004 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Barclays increased their price objective on shares of CME Group from $209.00 to $219.00 and gave the stock an "equal weight" rating in a research report on Monday, October 7th. Keefe, Bruyette & Woods upped their price objective on CME Group from $212.00 to $213.00 and gave the stock a "market perform" rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. increased their price objective on CME Group from $187.00 to $191.00 and gave the stock an "underweight" rating in a report on Thursday, July 25th. TD Cowen initiated coverage on CME Group in a research note on Thursday, September 26th. They issued a "hold" rating and a $221.00 target price on the stock. Finally, Morgan Stanley lifted their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an "equal weight" rating in a report on Thursday. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $220.07.

Insider Buying and Selling at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company's stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company's stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the company's stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company's stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company's stock.

CME Group Stock Performance

NASDAQ CME traded up $1.09 during trading on Friday, reaching $228.32. 1,203,010 shares of the company's stock were exchanged, compared to its average volume of 1,941,867. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The business has a 50 day moving average price of $216.92 and a 200-day moving average price of $208.34. The stock has a market capitalization of $82.21 billion, a P/E ratio of 25.97, a PEG ratio of 7.76 and a beta of 0.55. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.12.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same period last year, the business posted $2.30 earnings per share. The business's revenue for the quarter was up 12.7% compared to the same quarter last year. Sell-side analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date of this dividend was Monday, September 9th. CME Group's dividend payout ratio is currently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.